Valsartan-d9

• CAT Number: S000108
• CAS Number: 1089736-73-1
• Molecular Formula: C24H20D9N5O3
• Molecular Weight: 444.57
• Purity: ≥95%
• Target: Angiotensin Receptor
• IUPAC Name: (2S)-3-methyl-2-[2,2,3,3,4,4,5,5,5-nonadeuteriopentanoyl-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]amino]butanoic acid
• InChI: InChI=1S/C24H29N5O3/c1-4-5-10-21(30)29(22(16(2)3)24(31)32)15-17-11-13-18(14-12-17)19-8-6-7-9-20(19)23-25-27-28-26-23/h6-9,11-14,16,22H,4-5,10,15H2,1-3H3,(H,31,32)(H,25,26,27,28)/t22-/m0/s1/i1D3,4D2,5D2,10D2
• InChIKey: ACWBQPMHZXGDFX-KDDXQTGLSA-N
• SMILES: [2H]C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C(=O)N(CC1=CC=C(C=C1)C2=CC=CC=C2C3=NNN=N3)[C@@H](C(C)C)C(=O)O

Valsartan-d9 (CAS: 1089736-73-1), a high-quality pharmaceutical research compound designed for advanced studies in hypertension and cardiovascular research. As a deuterated analog of Valsartan, it offers enhanced stability and improved pharmacokinetic properties. Valsartan-d9 is ideal for use in pharmacological and biochemical research, providing precise and reliable data for your studies. This high-purity compound ensures consistent results, aiding in the development of novel therapies for hypertension and heart failure. Trusted by leading laboratories, Valsartan-d9 is your go-to solution for cutting-edge cardiovascular research. Unlock new possibilities in hypertension and heart disease treatment with Valsartan-d9, where innovation meets reliability.

Reference

[1]. Shan H, et al. Valsartan ameliorates ageing-induced aorta degeneration via angiotensin II type 1 receptor-mediated ERK activity. J Cell Mol Med. 2014 Jun;18(6):1071-80.
[Content Brief]